Skip to main content

Advertisement

SpringerLink
Log in

Obstructive Sleep Apnea and Cardiovascular Disease

  • Prevention
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Obstructive sleep apnea is a highly prevalent disease that often goes undetected for many years before diagnosis. Although most patients seek treatment to improve symptoms of daytime sleepiness, a growing body of literature suggests that treatment may also modulate cardiovascular risk. This article summarizes the current literature regarding the associations between sleep-disordered breathing and adverse cardiovascular outcomes and reviews the lesser body of data demonstrating the cardiovascular benefits of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Young T, Palta M, Dempsey J, et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328(17):1230–1235.

    Article  PubMed  CAS  Google Scholar 

  2. Wright J, Johns R, Watt I, et al.: Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. BMJ 1997, 314(7084):851–860.

    PubMed  CAS  Google Scholar 

  3. Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165(9):1217–1239.

    Article  PubMed  Google Scholar 

  4. Nieto FJ, Young TB, Lind BK, et al.: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study JAMA 2000, 283(14):1829–1836.

    CAS  Google Scholar 

  5. Peker Y, Carlson J, Hedner J: Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006, 28(3):596–602.

    Article  PubMed  CAS  Google Scholar 

  6. Gami AS, Hodge DO, Herges RM, et al.: Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007, 49(5):565–571.

    Article  PubMed  Google Scholar 

  7. Mehra R, Benjamin EJ, Shahar E, et al.: Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006, 173(8):910–916.

    Article  PubMed  Google Scholar 

  8. Arzt M, Young T, Finn L, et al.: Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005, 172(11):1447–1451.

    Article  PubMed  Google Scholar 

  9. Kasai T, Narui K, Dohi T, et al.: Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008, 133(3):690–696.

    Article  PubMed  Google Scholar 

  10. Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365(9464):1046–1053.

    PubMed  Google Scholar 

  11. Young T, Finn L, Peppard PE, et al.: Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008, 31(8):1071–1078.

    PubMed  Google Scholar 

  12. Marshall NS, Wong KK, Liu PY, et al.: Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008, 31(8):1079–1085.

    PubMed  Google Scholar 

  13. Bixler EO, Vgontzas AN, Lin HM, et al.: Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160(15):2289–2295.

    Article  PubMed  CAS  Google Scholar 

  14. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342(19):1378–1384.

    Article  PubMed  CAS  Google Scholar 

  15. Logan AG, Tkacova R, Perlikowski SM, et al.: Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003, 21(2):241–247.

    Article  PubMed  CAS  Google Scholar 

  16. Alajmi M, Mulgrew AT, Fox J, et al.: Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007, 185(2):67–72.

    Article  PubMed  CAS  Google Scholar 

  17. Haentjens P, Van Meerhaeghe A, Moscariello A, et al.: The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007, 167(8):757–764.

    Article  PubMed  Google Scholar 

  18. Lenfant C: Do sleep disorders have an impact on blood pressure? Am J Ther 2008, 15(4):345–350.

    Article  PubMed  Google Scholar 

  19. Young T, Peppard PE, Taheri S: Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99(4):1592–1599.

    Article  PubMed  Google Scholar 

  20. O’Connor GT, Caffo B, Newman AB, et al.: Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009, 179(12):1159–1164.

    Article  PubMed  Google Scholar 

  21. Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96(4):1897–1904.

    Article  PubMed  CAS  Google Scholar 

  22. Hla KM, Young T, Finn L, et al.: Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 2008, 31(6):795–800.

    PubMed  Google Scholar 

  23. Kato M, Roberts-Thomson P, Phillips BG, et al.: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000, 102(21):2607–2610.

    PubMed  CAS  Google Scholar 

  24. Schafer H, Koehler U, Ploch T, Peter JH: Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 1997, 111(2):387–393.

    Article  PubMed  CAS  Google Scholar 

  25. Punjabi NM, Caffo BS, Goodwin JL, et al.: Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6(8):e1000132.

    Article  PubMed  Google Scholar 

  26. Sahlin C, Sandberg O, Gustafson Y, et al.: Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008, 168(3):297–301.

    Article  PubMed  Google Scholar 

  27. Peker Y, Kraiczi H, Hedner J, et al.: An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999, 14(1):179–184.

    Article  PubMed  CAS  Google Scholar 

  28. Shah NA, Yaggi HK, Concato J, Mohsenin V: Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death. Sleep Breath 2009 Sep 24 (Epub ahead of print).

  29. Gami AS, Howard DE, Olson EJ, Somers VK: Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005, 352(12):1206–1214.

    Article  PubMed  CAS  Google Scholar 

  30. Shahar E, Whitney CW, Redline S, et al.: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163(1):19–25.

    PubMed  CAS  Google Scholar 

  31. Valham F, Mooe T, Rabben T, et al.: Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 2008, 118(9):955–960.

    Article  PubMed  Google Scholar 

  32. Mooe T, Franklin KA, Holmstrom K, et al.: Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001, 164(10 Pt 1):1910–1913.

    PubMed  CAS  Google Scholar 

  33. Yaggi HK, Concato J, Kernan WN, et al.: Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005, 353(19):2034–2041.

    Article  PubMed  CAS  Google Scholar 

  34. Bassetti CL, Milanova M, Gugger M: Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006, 37(4):967–972.

    Article  PubMed  Google Scholar 

  35. Parra O, Arboix A, Bechich S, et al.: Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000, 161(2 Pt 1):375–380.

    PubMed  CAS  Google Scholar 

  36. Netzer N, Werner P, Jochums I, et al.: Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998, 29(1):87–93.

    PubMed  CAS  Google Scholar 

  37. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al.: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002, 105(21):2462–2464.

    Article  PubMed  CAS  Google Scholar 

  38. Sanner BM, Konermann M, Tepel M, et al.: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000, 16(4):648–652.

    Article  PubMed  CAS  Google Scholar 

  39. Oga T, Chin K, Tabuchi A, et al.: Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability. J Atheroscler Thromb 2009, 16(6):862–869.

    PubMed  Google Scholar 

  40. Ziegler MG, Nelesen R, Mills P, et al.: Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep 1997, 20(3):224–231.

    PubMed  CAS  Google Scholar 

  41. Larsson PT, Wallen NH, Egberg N, Hjemdahl P: Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci (Lond) 1992, 82(4):369–376.

    CAS  Google Scholar 

  42. Reinhart WH, Oswald J, Walter R, Kuhn M: Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clin Hemorheol Microcirc 2002, 27(3–4):201–207.

    PubMed  CAS  Google Scholar 

  43. Chin K, Ohi M, Kita H, et al.: Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996, 153(6 Pt 1):1972–1976.

    PubMed  CAS  Google Scholar 

  44. Savransky V, Nanayakkara A, Li J, et al.: Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 2007, 175(12):1290–1297.

    Article  PubMed  CAS  Google Scholar 

  45. Ohga E, Nagase T, Tomita T, et al.: Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999, 87(1):10–14.

    PubMed  CAS  Google Scholar 

  46. Dyugovskaya L, Polyakov A, Lavie P, Lavie L: Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 2008, 177(5):544–554.

    Article  PubMed  CAS  Google Scholar 

  47. Ip MS, Lam B, Ng MM, et al.: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165(5):670–676.

    PubMed  Google Scholar 

  48. Olson LJ, Somers VK: Sleep apnea: implications for heart failure. Curr Heart Fail Rep 2007, 4(2):63–69.

    Article  PubMed  Google Scholar 

  49. Hanly P, Zuberi-Khokhar N: Daytime sleepiness in patients with congestive heart failure and Cheyne-Stokes respiration. Chest 1995, 107(4):952–958.

    Article  PubMed  CAS  Google Scholar 

  50. Wang H, Parker JD, Newton GE, et al.: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49(15):1625–1631.

    Article  PubMed  Google Scholar 

  51. Javaheri S, Shukla R, Zeigler H, Wexler L: Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J Am Coll Cardiol 2007, 49(20):2028–2034.

    Article  PubMed  Google Scholar 

  52. Gami AS, Pressman G, Caples SM, et al.: Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110(4):364–367.

    Article  PubMed  Google Scholar 

  53. Kanagala R, Murali NS, Friedman PA, et al.: Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003, 107(20):2589–2594.

    PubMed  Google Scholar 

  54. Somers VK, Dyken ME, Mark AL, Abboud FM: Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension. Clin Auton Res 1992, 2(3):171–176.

    Article  PubMed  CAS  Google Scholar 

  55. Otto ME, Belohlavek M, Romero-Corral A, et al.: Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007, 99(9):1298–1302.

    Article  PubMed  Google Scholar 

  56. Sauer WH, McKernan ML, Lin D, et al.: Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006, 3(9):1024–1028.

    Article  PubMed  Google Scholar 

  57. Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al.: Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005, 128(2):624–633.

    Article  PubMed  Google Scholar 

  58. Milleron O, Pilliere R, Foucher A, et al.: Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004, 25(9):728–734.

    Article  PubMed  Google Scholar 

  59. Drager LF, Bortolotto LA, Figueiredo AC, et al.: Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2007, 176(7):706–712.

    Article  PubMed  CAS  Google Scholar 

  60. Hanly P, Sasson Z, Zuberi N, Lunn K: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993, 71(15):1341–1345.

    Article  PubMed  CAS  Google Scholar 

  61. Franklin KA, Nilsson JB, Sahlin C, Naslund U: Sleep apnoea and nocturnal angina. Lancet 1995, 345(8957):1085–1087.

    Article  PubMed  CAS  Google Scholar 

  62. Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 348(13):1233–1241.

    PubMed  Google Scholar 

  63. Ryan CM, Usui K, Floras JS, Bradley TD: Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea. Thorax 2005, 60(9):781–785.

    Article  PubMed  CAS  Google Scholar 

  64. Usui K, Bradley TD, Spaak J, et al.: Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005, 45(12):2008–2011.

    Article  PubMed  Google Scholar 

  65. Javaheri S: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000, 101(4):392–397.

    PubMed  CAS  Google Scholar 

  66. Khayat RN, Abraham WT, Patt B, et al.: In-hospital treatment of obstructive sleep apnea during decompensation of heart failure. Chest 2009, 136(4):991–997.

    Article  PubMed  Google Scholar 

  67. Pepperell JC, Maskell NA, Jones DR, et al.: A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168(9):1109–1114.

    Article  PubMed  Google Scholar 

  68. Teschler H, Dohring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 164(4):614–619.

    PubMed  CAS  Google Scholar 

  69. Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107(1):68–73.

    Article  PubMed  Google Scholar 

  70. Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006, 47(5):840–845.

    Article  PubMed  CAS  Google Scholar 

  71. Guilleminault C, Connolly SJ, Winkle RA: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983, 52(5):490–494.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

Dr. Schulman was a member of the GlaxoSmithKline speakers bureau. No other potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Division of Pulmonary, Allergy and Critical Care Medicine, Emory University School of Medicine, 1365 Clifton Road Northeast, Building A-4, Atlanta, GA, 30322, USA

    David E. Green MD & David A. Schulman MD, MPH

Authors
  1. David E. Green MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David A. Schulman MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David A. Schulman MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Green, D.E., Schulman, D.A. Obstructive Sleep Apnea and Cardiovascular Disease. Curr Treat Options Cardio Med 12, 342–354 (2010). https://doi.org/10.1007/s11936-010-0082-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-010-0082-9

Keywords

Search

Navigation